Home
>
US Stocks
>
Pacira BioSciences Inc
Pacira BioSciences Inc
PCRX

Pacira BioSciences Inc (PCRX)

$61.243.24%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$62.96
Today Low/High$60.9 / $62.96
52 Week Low/High$45.05 / $80
P/E ratio45.62
Market Cap$2.86B

Company Details

Pacira BioSciences, Inc.is the industry leader in its commitment to non-opioid pain management and regenerative health solutions to improve patients' journeys along the neural pain pathway. The company's long-acting local analgesic, EXPAREL ® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019, Pacira acquired the iovera° system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves.
OrganisationPacira BioSciences Inc
HeadquatersParsippany, New Jersey, US
Employees624
IndustryHealth Technology

Discover more

Frequently Asked Questions

What is Pacira BioSciences Inc (PCRX) share price today?

Can Indians buy Pacira BioSciences Inc (PCRX) shares?

How can I buy Pacira BioSciences Inc (PCRX) shares from India?

Can Fractional shares of Pacira BioSciences Inc (PCRX) be purchased?

What are the documents required to start investing in Pacira BioSciences Inc (PCRX) stocks?